Mobidiag Extends Agreement with Biomedica Medizinprodukte GmbH & Co KG for Distribution of Amplidiag® Diagnostics Tests in Central and Eastern Europe (CEE)
Mobidiag Ltd, a Finnish molecular diagnostics company, today announced an agreement with Biomedica Medizinprodukte GmbH & Co KG, provider of a large panel of medical products for health professionals, medical scientists, and research laboratories, for the distribution of the Amplidiag® product line. Under this new agreement Biomedica Medizinprodukte becomes the exclusive distributor of Amplidiag®, in vitro diagnostics for gastrointestinal infections, in Central and Eastern Europe (Austria, Bosnia & Herzegovina, Bulgaria, Croatia, Czech Republic, Hungary, Macedonia, Poland, Romania, Serbia, Slovakia, Slovenia).
“Since Mobidiag’s inception, we have been focusing our activity towards Nordic region and France mainly. Three months ago, we have started developing our distribution network by extending our European coverage to Spain and Benelux. We are very pleased today to expand Amplidiag accessibility to Central and Eastern Europe with the support of our partner, Biomedica Medizinprodukte” said Tuomas Tenkanen, CEO at Mobidiag.
“Rapid and reliable detection of gastrointestinal infections is crucial for preventing transmission of contagious pathogens. With Amplidiag products, we will ensure the distribution of innovative, quality products that will significantly impact infection control” said Dr. Michaela Weblacher, Executive Vice President at Biomedica.
The distribution agreement is effective immediately and covers all Amplidiag® products (Amplidiag® H. pylori+ClariR, Amplidiag® Stool Parasites, Amplidiag® CarbaR+VRE, Amplidiag® C. difficile+027, Amplidiag® Bacterial GE, Amplidiag® Easy and upcoming Amplidiag® Viral GE).
About Amplidiag®
Amplidiag® are innovative multiplex tests
for the detection of gastrointestinal infections. They allow to screen
simultaneously panels of the most relevant gastrointestinal pathogens.
Based on well-established real-time PCR technology, they ensure optimal
performance, suitability for high-volume screening use and
cost-effectiveness in mid-sized to large laboratory settings.
About Mobidiag
Established in 2000, Mobidiag develops
innovative solutions to advance the diagnosis of infectious diseases and
serves the European clinical diagnostics market since 2008. Mobidiag is
headquartered in Espoo, Finland, with a subsidiary in Paris, France.
In addition to Amplidiag® assays, Mobidiag is able to address both high
volume and on demand testing with the new Amplidiag® Easy platform,
bringing the Amplidiag® suite further by automating the workflow from
sample to results, and the upcoming Novodiag® platform & associated
panels for a fully automated solution and suitable for smaller volumes
and labs.
Visit www.mobidiag.com
for more information.
About Biomedica Medizinprodukte GmbH & Co KG
With 13
offices in Central and Eastern Europe (CEE) and a team of more than 250
professionals, Biomedica is a leading distributor of medical devices,
in-vitro diagnostics, products for life sciences, Biomedica Immunoassays
and Clinical IT. With its headquarter in Vienna, Austria, Biomedica is
dedicated to strive for excellence, i.e. state-of-the-art products,
uncompromising professionalism in customer support and the best possible
service, in order to meet all customer demands at the highest level.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160904005004/en/
Contact information
Mobidiag Ltd.
Anne Aittakorpi, +358 10 5050 770
info@mobidiag.com
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
China's 2024 Labor Day Sees 77% Rise in Outbound Travel Transactions and 700% Surge in Inbound Spending YoY via Alipay5.5.2024 16:29:00 CEST | Press release
Alipay's data indicates a significant uptick in both outbound and inbound tourism spending in China during the 2024 Labor Day holiday. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240505795104/en/ The salesperson welcomes Chinese travelers to use Alipay for payment at Designer Outlet Roermond in the Netherlands (Photo: Business Wire) Outbound Tourism Transactions by Alipay users in overseas markets during the initial two days of the holiday saw a substantial 77% increase from the corresponding period in 2023, with total spending rising by 10% year-on-year. For the 2024 Labor Day holiday, Alipay, an Alipay+ partner wallet, has joined hands with global merchants to launch extensive campaigns aimed at enticing Chinese tourists. Enabled by Alipay+, a suite of cross-border digital payment and digitalization technology solutions connecting global brands with mobile-savvy consumers worldwide, Chinese travelers can seamlessly pay
MOGAS Mourns the Death of Their Beloved Chairman and Founder Vincent Louis Mogas3.5.2024 19:30:00 CEST | Press release
MOGAS mourns the death of their beloved chairman and founder Vincent Louis Mogas, who died on May 2, 2024 in Houston, Texas. Louis spent his life building a valve manufacturing business and a company culture that stood for goodness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240503919754/en/ V. Louis Mogas, Founder and Chairman of MOGAS Industries (1939 - 2024) (Photo: MOGAS Industries Inc.) MOGAS Industries was formed in May 1973 when Louis Mogas purchased a small machine shop in Houston. He soon acquired the rights to service and manufacture ball valves from Cameron Iron Works. Under Louis' leadership, the Company studied valve failures and established an R&D department that customized valves for specific applications. Since 2000, MOGAS has established sales and service offices in Australia, China, Europe, Canada, South America, Middle East and India. Early on, Louis Mogas introduced business behaviors that became the
Ververica Achieves ISO 27001 Certification, Bolstering Data Security3.5.2024 18:08:00 CEST | Press release
Ververica, a comprehensive streaming data platform provider, announces the achievement of ISO 27001 certification, a significant milestone in its commitment to data security and governance. This certification is internationally recognized as the gold standard for information security management systems (ISMS), and demonstrates the company’s commitment to protecting sensitive corporate and customer data against emerging cyber threats. For Ververica and its customers, this ensures that data is managed under the strictest security protocols, enhancing trust and confidence in Ververica’s ability to handle sensitive information securely and effectively. Ververica's security operations utilize Vanta, a trusted third-party management platform, for rigorous real-time monitoring and security alerts. To further enhance transparency and customer trust, Ververica has introduced a dedicated Trust Center webpage where stakeholders and potential customers can review live detailed information about se
Lone Star Announces Acquisition of ERIKS3.5.2024 15:07:00 CEST | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate has acquired ERIKS N.V., a specialized pan-European industrial components distributor and engineering service provider. Financial terms of the transaction were not disclosed. Founded in 1940, ERIKS has established itself as a European leader in specialized industrial services with over 200 locations in 12 countries. ERIKS’ deep industry experience, technical knowledge, local distribution network and dedicated engineering facilities allow it to develop advanced, customized solutions that drive performance improvements, deliver cost savings and add measurable technical and commercial value for its customers. Donald Quintin, Chief Executive Officer and Global President of Lone Star, said, "ERIKS represents an exciting investment opportunity and a valuable addition to our European investment portfolio. This acquisition aligns with our strategy of investing in market leading businesses that exhibit both growth and operating imp
Mars, Incorporated Enters Exclusive Discussions to Acquire the Entire Stake in French Veterinary Diagnostics Businesses Cerba Vet and ANTAGENE Held by the Cerba HealthCare Group3.5.2024 15:00:00 CEST | Press release
Mars, Incorporated today announced that it has entered into exclusive discussions with Cerba HealthCare with a view to acquiring Cerba HealthCare’s ownership stake in Cerba Vet and ANTAGENE. Headquartered in Massy, France, Cerba Vet is a network of six veterinary diagnostics laboratories in France and Switzerland. With approximately 140 Associates, Cerba Vet provides full animal-related service diagnostics with complete clinical and anatomic pathology testing as well as endocrinology, microbiology, serology, hematology, chemistry, and other advanced tests, to veterinary practitioners. Cerba Vet is recognized by veterinarians in France for its medical expertise and pioneering continuous education program, the Cerba Vet College, with weekly live webinars and several practical sessions annually. Headquartered in Lyon, France, ANTAGENE is a leading player in animal genetics in Europe, recognised for its expertise in DNA testing for dogs, cats, horses and wildlife. ANTAGENE offers tests glo